Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Newmont Mining | 2.44% | $446.24M | $127.51B | 159.90% | 81 Outperform | |
| Exxon Mobil | 2.38% | $434.64M | $622.41B | 34.32% | 74 Outperform | |
| Chevron | 2.29% | $418.29M | $364.91B | 18.46% | 71 Outperform | |
| Gilead Sciences | 2.28% | $416.56M | $181.42B | 46.74% | 78 Outperform | |
| Merck & Company | 2.24% | $409.38M | $293.70B | 31.96% | 80 Outperform | |
| Conocophillips | 2.16% | $394.62M | $132.95B | 7.36% | 78 Outperform | |
| Verizon | 2.14% | $390.96M | $198.21B | 17.14% | 81 Outperform | |
| Altria Group | 2.13% | $389.91M | $109.38B | 23.92% | 64 Neutral | |
| Comcast | 2.10% | $384.04M | $109.73B | -10.14% | 74 Outperform | |
| Bristol-Myers Squibb | 2.07% | $378.37M | $117.30B | -3.50% | 78 Outperform |